Lisata Net Income Applicable To Common Shares from 2010 to 2026
| LSTA Stock | USD 4.64 0.01 0.22% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -24.7 M | Current Value -26 M | Quarterly Volatility 5.9 M |
Check Lisata Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lisata Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 190.1 K, Interest Expense of 2.4 M or Selling General Administrative of 7.5 M, as well as many indicators such as Price To Sales Ratio of 27.12, Dividend Yield of 0.76 or PTB Ratio of 0.79. Lisata financial statements analysis is a perfect complement when working with Lisata Therapeutics Valuation or Volatility modules.
Lisata | Net Income Applicable To Common Shares | Build AI portfolio with Lisata Stock |
Analyzing Lisata Therapeutics's Net Income Applicable To Common Shares over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income Applicable To Common Shares has evolved provides context for assessing Lisata Therapeutics's current valuation and future prospects.
Latest Lisata Therapeutics' Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Lisata Therapeutics over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Lisata Therapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lisata Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Lisata Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (19,620,751) | |
| Coefficient Of Variation | (29.92) | |
| Mean Deviation | 5,036,972 | |
| Median | (16,167,000) | |
| Standard Deviation | 5,870,033 | |
| Sample Variance | 34.5T | |
| Range | 19.3M | |
| R-Value | (0.69) | |
| Mean Square Error | 19.1T | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | (805,676) | |
| Total Sum of Squares | 551.3T |
Lisata Net Income Applicable To Common Shares History
About Lisata Therapeutics Financial Statements
Lisata Therapeutics stakeholders use historical fundamental indicators, such as Lisata Therapeutics' Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Lisata Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Lisata Therapeutics' assets and liabilities are reflected in the revenues and expenses on Lisata Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Lisata Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -24.7 M | -26 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Lisata Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lisata Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lisata Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lisata Therapeutics Stock:Check out the analysis of Lisata Therapeutics Correlation against competitors. For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lisata Therapeutics. Expected growth trajectory for Lisata significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Lisata Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Lisata Therapeutics is measured differently than its book value, which is the value of Lisata that is recorded on the company's balance sheet. Investors also form their own opinion of Lisata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Lisata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lisata Therapeutics' market value can be influenced by many factors that don't directly affect Lisata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Lisata Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lisata Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Lisata Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.